Identification of TMEM131L as a novel regulator of thymocyte proliferation in humans

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6187-6197

  Maharzi, Nesrine ^a,b,c   Parietti, Véronique ^a,b,c   Nelson, Elisabeth ^a,b,c   Denti, Simona ^a,b,c   Robledo Sarmiento, Macarena ^a,b,c   Setterblad, Niclas ^d   Parcelier, Aude ^a,b,c   Pla, Marika ^d   Sigaux, François ^a,b,c   Gluckman, Jean Claude ^a,b,c   Canque, Bruno ^a,b,c  

^a PSL RESEARCH UNIVERSITY   (France)

^b Institut Universitaire d'Hématologie   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MEMBRANE PROTEIN; TRANSMEMBRANE PROTEIN 131 LIKE; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DEVELOPMENTAL DISORDER; DEVELOPMENTAL STAGE; EMBRYO; EXTRACELLULAR MATRIX; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE MAPPING; GENE TARGETING; HEMATOPOIESIS; HUMAN; HUMAN CELL; LYSOSOME; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; THYMOCYTE; THYMOPOIESIS; THYMUS DISEASE; WNT SIGNALING PATHWAY;

ANIMALS; CELL PROLIFERATION; FLOW CYTOMETRY; HEK293 CELLS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; MICROSCOPY, FLUORESCENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMOCYTES; WNT SIGNALING PATHWAY;

EID: 84879124551     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300400     Document Type: Article

References (44)

1. Haddad, R., F. Guimiot, E. Six, F. Jourquin, N. Setterblad, E. Kahn, M. Yagello, C. Schiffer, I. Andre-Schmutz, M. Cavazzana-Calvo, et al. 2006. Dynamics of thymus-colonizing cells during human development. Immunity 24: 217-230. (Pubitemid 43214590)
2. Maillard, I., T. Fang, and W. S. Pear. 2005. Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu. Rev. Immunol. 23: 945-974. (Pubitemid 40563190)
3. Dik, W. A., K. Pike-Overzet, F. Weerkamp, D. de Ridder, E. F. de Haas, M. R. Baert, P. van der Spek, E. E. Koster, M. J. Reinders, J. J. van Dongen, et al. 2005. New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J. Exp. Med. 201: 1715-1723. (Pubitemid 41002890)
4. Rothenberg, E. V., J. E. Moore, and M. A. Yui. 2008. Launching the T-cell-lineage developmental programme. Nat. Rev. Immunol. 8: 9-21.
5. Spits, H. 2002. Development of αβ T cells in the human thymus. Nat. Rev. Immunol. 2: 760-772.
6. Blom, B., M. H. Heemskerk, M. C. Verschuren, J. J. van Dongen, A. P. Stegmann, A. Q. Bakker, F. Couwenberg, P. C. Res, and H. Spits. 1999. Disruption of αβ but not of γδ T cell development by overexpression of the helix-loop-helix protein Id3 in committed T cell progenitors. EMBO J. 18: 2793-2802. (Pubitemid 29233951)
7. Blom, B., M. C. Verschuren, M. H. Heemskerk, A. Q. Bakker, E. J. van Gastel-Mol, I. L. Wolvers-Tettero, J. J. van Dongen, and H. Spits. 1999. TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation. Blood 93: 3033-3043. (Pubitemid 29200796)
8. Agata, Y., N. Tamaki, S. Sakamoto, T. Ikawa, K. Masuda, H. Kawamoto, and C. Murre. 2007. Regulation of T cell receptor β gene rearrangements and allelic exclusion by the helix-loop-helix protein, E47. Immunity 27: 871-884. (Pubitemid 350251223)
9. Bain, G., I. Engel, E. C. Robanus Maandag, H. P. te Riele, J. R. Voland, L. L. Sharp, J. Chun, B. Huey, D. Pinkel, and C. Murre. 1997. E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17: 4782-4791. (Pubitemid 27318153)
10. Engel, I., and C. Murre. 2004. E2A proteins enforce a proliferation checkpoint in developing thymocytes. EMBO J. 23: 202-211. (Pubitemid 38165760)
11. Wojciechowski, J., A. Lai, M. Kondo, and Y. Zhuang. 2007. E2A and HEB are required to block thymocyte proliferation prior to pre-TCR expression. J. Immunol. 178: 5717-5726. (Pubitemid 46674368)
12. Kathrein, K. L., R. Lorenz, A. M. Innes, E. Griffiths, and S. Winandy. 2005. Ikaros induces quiescence and T-cell differentiation in a leukemia cell line. Mol. Cell. Biol. 25: 1645-1654. (Pubitemid 40280134)
13. Beverly, L. J., and A. J. Capobianco. 2003. Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in NotchIC-induced T cell leukemogenesis. Cancer Cell 3: 551-564. (Pubitemid 36808650)
14. Dumortier, A., R. Jeannet, P. Kirstetter, E. Kleinmann, M. Sellars, N. R. dos Santos, C. Thibault, J. Barths, J. Ghysdael, J. A. Punt, et al. 2006. Notch activation is an early and critical event during T-cell leukemogenesis in Ikaros-deficient mice. Mol. Cell. Biol. 26: 209-220.
15. Kleinmann, E., A. S. Geimer Le Lay, M. Sellars, P. Kastner, and S. Chan. 2008. Ikaros represses the transcriptional response to Notch signaling in T-cell development. Mol. Cell. Biol. 28: 7465-7475.
16. Winandy, S., P. Wu, and K. Georgopoulos. 1995. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83: 289-299.
17. Fukushima, T., J. M. Zapata, N. C. Singha, M. Thomas, C. L. Kress, M. Krajewska, S. Krajewski, Z. Ronai, J. C. Reed, and S. Matsuzawa. 2006. Critical function for SIP, a ubiquitin E3 ligase component of the b-catenin degradation pathway, for thymocyte development and G1 checkpoint. Immunity 24: 29-39. (Pubitemid 43077198)
18. Cobas, M., A. Wilson, B. Ernst, S. J. Mancini, H. R. MacDonald, R. Kemler, and F. Radtke. 2004. β-catenin is dispensable for hematopoiesis and lymphopoiesis. J. Exp. Med. 199: 221-229.
19. Jeannet, G., M. Scheller, L. Scarpellino, S. Duboux, N. Gardiol, J. Back, F. Kuttler, I. Malanchi, W. Birchmeier, A. Leutz, et al. 2008. Long-term, multi-lineage hematopoiesis occurs in the combined absence of β-catenin and γ-catenin. Blood 111: 142-149.
20. Parcelier, A., N. Maharzi, M. Delord, M. Robledo-Sarmiento, E. Nelson, H. Belakhdar-Mekid, M. Pla, K. Kuranda, V. Parietti, M. Goodhardt, et al. 2011. AF1q/MLLT11 regulates the emergence of human prothymocytes through cooperative interaction with the Notch signaling pathway. Blood 118: 1784-1796.
21. null mice. J. Immunol. 189: 1648-1660.
22. Li, V. S., S. S. Ng, P. J. Boersema, T. Y. Low, W. R. Karthaus, J. P. Gerlach, S. Mohammed, A. J. Heck, M. M. Maurice, T. Mahmoudi, and H. Clevers. 2012. Wnt signaling through inhibition of b-catenin degradation in an intact Axin1 complex. Cell 149: 1245-1256.
23. Weerkamp, F., M. R. Baert, B. A. Naber, E. E. Koster, E. F. de Haas, K. R. Atkuri, J. J. van Dongen, L. A. Herzenberg, and F. J. Staal. 2006. Wnt signaling in the thymus is regulated by differential expression of intracellular signaling molecules. Proc. Natl. Acad. Sci. USA 103: 3322-3326. (Pubitemid 43346468)
24. Tamai, K., X. Zeng, C. Liu, X. Zhang, Y. Harada, Z. Chang, and X. He. 2004. A mechanism for Wnt coreceptor activation. Mol. Cell 13: 149-156. (Pubitemid 38117123)
25. Niehrs, C. 2012. The complex world of WNT receptor signalling. Nat. Rev. Mol. Cell Biol. 13: 767-779.
26. +-ATPase-mediated acidification for Wnt signaling. Science 327: 459-463.
27. Yamamoto, H., H. Komekado, and A. Kikuchi. 2006. Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of β-catenin. Dev. Cell 11: 213-223. (Pubitemid 44138502)
28. Jiang, Y., X. He, and P. H. Howe. 2012. Disabled-2 (Dab2) inhibits Wnt/β-catenin signalling by binding LRP6 and promoting its internalization through clathrin. EMBO J. 31: 2336-2349.
29. Yamamoto, H., H. Sakane, H. Yamamoto, T. Michiue, and A. Kikuchi. 2008. Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of β-catenin signaling. Dev. Cell 15: 37-48. (Pubitemid 351895596)
30. Gandillet, A., S. Park, F. Lassailly, E. Griessinger, J. Vargaftig, A. Filby, T. A. Lister, and D. Bonnet. 2011. Heterogeneous sensitivity of human acute myeloid leukemia to b-catenin down-modulation. Leukemia 25: 770-780.
31. Staal, F. J., T. C. Luis, and M. M. Tiemessen. 2008. WNT signalling in the immune system: WNT is spreading its wings. Nat. Rev. Immunol. 8: 581-593.
32. Mulroy, T., J. A. McMahon, S. J. Burakoff, A. P. McMahon, and J. Sen. 2002. Wnt-1 and Wnt-4 regulate thymic cellularity. Eur. J. Immunol. 32: 967-971. (Pubitemid 34428811)
33. Luis, T. C., F. Weerkamp, B. A. Naber, M. R. Baert, E. F. de Haas, T. Nikolic, S. Heuvelmans, R. R. De Krijger, J. J. van Dongen, and F. J. Staal. 2009. Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation. Blood 113: 546-554.
34. Osada, M., E. Ito, H. A. Fermin, E. Vazquez-Cintron, T. Venkatesh, R. H. Friedel, and M. Pezzano. 2006. The Wnt signaling antagonist Kremen1 is required for development of thymic architecture. Clin. Dev. Immunol. 13: 299-319. (Pubitemid 44950046)
35. Osada, M., L. Jardine, R. Misir, T. Andl, S. E. Millar, and M. Pezzano. 2010. DKK1 mediated inhibition of Wnt signaling in postnatal mice leads to loss of TEC progenitors and thymic degeneration. PLoS ONE 5: e9062.
36. Staal, F. J., J. Meeldijk, P. Moerer, P. Jay, B. C. van de Weerdt, S. Vainio, G. P. Nolan, and H. Clevers. 2001. Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription. Eur. J. Immunol. 31: 285-293.
37. Hsu, W., R. Shakya, and F. Costantini. 2001. Impaired mammary gland and lymphoid development caused by inducible expression of Axin in transgenic mice. J. Cell Biol. 155: 1055-1064. (Pubitemid 34286255)
38. Pongracz, J. E., S. M. Parnell, T. Jones, G. Anderson, and E. J. Jenkinson. 2006. Overexpression of ICAT highlights a role for catenin-mediated canonical Wnt signalling in early T cell development. Eur. J. Immunol. 36: 2376-2383. (Pubitemid 44420594)
39. Okamura, R. M., M. Sigvardsson, J. Galceran, S. Verbeek, H. Clevers, and R. Grosschedl. 1998. Redundant regulation of T cell differentiation and TCRα gene expression by the transcription factors LEF-1 and TCF-1. Immunity 8: 11-20. (Pubitemid 28097819)
40. Schilham, M. W., A. Wilson, P. Moerer, B. J. Benaissa-Trouw, A. Cumano, and H. C. Clevers. 1998. Critical involvement of Tcf-1 in expansion of thymocytes. J. Immunol. 161: 3984-3991.
41. Verbeek, S., D. Izon, F. Hofhuis, E. Robanus-Maandag, H. te Riele, M. van de Wetering, M. Oosterwegel, A. Wilson, H. R. MacDonald, and H. C. Clevers. 1995. An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 374: 70-74.
42. Koch, U., and F. Radtke. 2011. Mechanisms of T cell development and transformation. Annu. Rev. Cell Dev. Biol. 27: 539-562.
43. Xu, M., A. Sharma, M. Z. Hossain, D. L. Wiest, and J. M. Sen. 2009. Sustained expression of pre-TCR induced β-catenin in post-β-selection thymocytes blocks T cell development. J. Immunol. 182: 759-765.
44. Xu, M., A. Sharma, D. L. Wiest, and J. M. Sen. 2009. Pre-TCR-induced β-catenin facilitates traversal through β-selection. J. Immunol. 182: 751-758.